Patents by Inventor Il Han Lee
Il Han Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11974420Abstract: A solid state drive apparatus includes a case including a base and side walls extending upward along a circumference of the base, an electrostatic prevention structure of a metal pillar spaced apart from the side walls and protruding from at least a partial surface of the base and an electrostatic absorbing member on at least a partial surface of the metal pillar, a package substrate module mounted on the electrostatic prevention structure in the case, and a cover covering the case and the package substrate module.Type: GrantFiled: January 4, 2023Date of Patent: April 30, 2024Assignee: Samsung Electronics Co., Ltd.Inventors: Sung-ki Lee, In-sub Kwak, Il-han Yun
-
Patent number: 11915782Abstract: An electronic device including a memory device with improved reliability is provided. The semiconductor device comprises a data pin configured to transmit a data signal, a command/address pin configured to transmit a command and an address, a command/address receiver connected to the command/address pin, and a computing unit connected to the command/address receiver, wherein the command/address receiver receives a first command and a first address from the outside through the command/address pin and generates a first instruction on the basis of the first command and the first address, and the computing unit receives the first instruction and performs computation based on the first instruction.Type: GrantFiled: August 20, 2021Date of Patent: February 27, 2024Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Chang Min Lee, Nam Hyung Kim, Dae Jeong Kim, Do Han Kim, Min Su Kim, Deok Ho Seo, Won Jae Shin, Yong Jun Yu, Il Gyu Jung, In Su Choi
-
Patent number: 11424729Abstract: A bulk-acoustic wave resonator includes a substrate, a first layer, a second layer, a membrane layer, and a resonance portion. The substrate includes a substrate protection layer. The first layer is disposed on the substrate protection layer. The second layer is disposed outside of the first layer. The membrane layer forms a cavity with the substrate protection layer and the first layer. The resonance portion is disposed on the membrane layer. Either one or both of the substrate protection layer and the membrane layer includes a protrusion disposed in the cavity.Type: GrantFiled: March 18, 2019Date of Patent: August 23, 2022Assignee: Samsung Electro-Mechanics Co., Ltd.Inventors: Tae Hun Lee, Tae Yoon Kim, Moon Chul Lee, Chang Hyun Lim, Nam Jung Lee, Il Han Lee
-
Publication number: 20200091888Abstract: A bulk-acoustic wave resonator includes a substrate, a first layer, a second layer, a membrane layer, and a resonance portion. The substrate includes a substrate protection layer. The first layer is disposed on the substrate protection layer. The second layer is disposed outside of the first layer. The membrane layer forms a cavity with the substrate protection layer and the first layer. The resonance portion is disposed on the membrane layer. Either one or both of the substrate protection layer and the membrane layer includes a protrusion disposed in the cavity.Type: ApplicationFiled: March 18, 2019Publication date: March 19, 2020Applicant: Samsung Electro-Mechanics Co., Ltd.Inventors: Tae Hun LEE, Tae Yoon KIM, Moon Chul LEE, Chang Hyun LIM, Nam Jung LEE, Il Han LEE
-
Publication number: 20200085857Abstract: Disclosed is a composition for alleviating symptoms of atopic dermatitis that contains a high molecular weight poly-gamma-glutamic acid and a low molecular weight poly-gamma-glutamic acid as active components. The composition for improving symptoms of atopic dermatitis inhibits epidermal and transepidermal water loss, improves desquamation (scaling skin), provides an excellent skin soothing effect, and relieves pruritus (itch) caused by dryness, thereby making remarkable improvement of general symptoms of atopic dermatitis.Type: ApplicationFiled: December 15, 2017Publication date: March 19, 2020Applicant: Bioleaders CorporationInventors: Jae-Chul Choi, IL-Han Lee, Heejin Cho, Seung Hoon Kim
-
Patent number: 10485823Abstract: The present invention is directed to a method of treating cervical intraepithelial neoplasia by administering a composition containing poly-gamma-glutamic acid. According to the present invention, cervical intraepithelial neoplasia in unmarried women, pre-childbirth women, or women who do not want infertility, can be treated without concern about infertility.Type: GrantFiled: April 18, 2016Date of Patent: November 26, 2019Assignee: BIOLEADERS CORPORATIONInventors: Il-Han Lee, Seung Hoon Kim, Min Young Park
-
Patent number: 9889186Abstract: An oral preparation for the prophylaxis or treatment of a disease with infection by a pathogen, containing a killed lactic acid bacterium expressing, on the surface, an antigen of the pathogen, or a microparticulated form thereof, which has an average particle size of 2.68-30 ?m. An oral preparation for inducing cellular immunity to a target antigen, containing a killed lactic acid bacterium expressing the target antigen on the surface or a microparticulated form thereof, which has a particle size of 2.68-30 ?m.Type: GrantFiled: April 18, 2014Date of Patent: February 13, 2018Assignees: MORISHITA JINTAN CO., LTD., BIOLEADERS CORPORATIONInventors: Takashi Nomura, Akiko Temma, Takahiro Nakazawa, Ryuichi Morishita, Il-Han Lee
-
Publication number: 20170296576Abstract: The present invention is directed to a method of treating cervical intraepithelial neoplasia by administering a composition containing poly-gamma-glutamic acid. According to the present invention, cervical intraepithelial neoplasia in unmarried women, pre-childbirth women, or women who do not want infertility, can be treated without concern about infertility.Type: ApplicationFiled: April 18, 2016Publication date: October 19, 2017Inventors: Il-Han Lee, Seung Hoon Kim, Min Young Park
-
Publication number: 20170249005Abstract: A display apparatus includes a display panel comprising a plurality of pixels, a voltage generator configured to generate a plurality of driving voltages for driving the display panel, a memory configured to store correction data for correcting image data corresponding to the plurality of pixels, and a controller configured to shut down the voltage generator and to block a driving voltage from being applied to the memory in response to a command signal including a deep-sleep command.Type: ApplicationFiled: January 31, 2017Publication date: August 31, 2017Inventors: Jong-Kwang HWANG, Il-Han LEE
-
Patent number: 9623121Abstract: The present invention relates to an optical imaging probe for detecting a sentinel lymph node, which contains a complex of poly-gamma-glutamic acid and an optical imaging dye, and more particularly to an optical imaging probe for detecting a sentinel lymph node, which contains a poly-gamma-glutamic acid/optical imaging dye complex that, when injected subcutaneously in vivo, remains in the sentinel lymph node for a relatively long period of time and has a low tendency to migrate to other lymph nodes. The present invention provides a poly-gamma-glutamic acid/fluorescent dye complex, which contains no radiopharmaceutical and is harmless to the human body. The use of the poly-gamma-glutamic acid/fluorescent dye complex makes it possible to accurately detect the position of a sentinel lymph node in real time without concerns about radioactive contamination.Type: GrantFiled: November 18, 2011Date of Patent: April 18, 2017Assignees: BIOLEADERS CORPORATION, THE INDUSTRY AND ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, KOOKMIN UNIVERSITY INDUSTRY - ACADEMIC COOPERATION FOUNDATIONInventors: Moon-Hee Sung, Yong Taik Lim, Young-Woock Noh, Il Han Lee
-
Publication number: 20160158274Abstract: The present invention relates to a composition for dispersing or hydrating mucus, which comprises poly-gamma-glutamic acid, a biocompatible natural polymer, and more particularly, to a composition for treating mucus hypersecretory disease, which comprises poly-gamma-glutamic acid or poly-gamma-glutamic acid nanogels. The composition according to the present invention is effective in treating mucus-related diseases by effectively dispersing and hydrating mucus which is excessively secreted in vivo and highly sticky.Type: ApplicationFiled: May 27, 2014Publication date: June 9, 2016Inventors: Il-Han Lee, Yong Taik Lim
-
Patent number: 9138491Abstract: The present invention relates to a nano-composite containing anionic and cationic polymers and a method for preparing thereof, and more particularly to a poly-gamma-glutamic acid (?-PGA)/chitosan/manganese iron oxide nanoparticle composite prepared by encapsulating iron oxide-based nanoparticles in a ?-PGA/chitosan polymer composite using the ionic self-assembly properties of poly-gamma-glutamic acid (?-PGA) and chitosan, which are biocompatible polymer materials, and to a method for preparing thereof. The present invention provides a magnetic resonance imaging nano-contrast agent based on a nanoparticle composite including iron oxide-based nanoparticles encapsulated in a self-assembled composite of anionic poly-gamma-glutamic acid (?PGA) and cationic chitosan.Type: GrantFiled: April 7, 2011Date of Patent: September 22, 2015Assignees: BIOLEADERS CORPORATION, THE INDUSTRY AND ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, KOOKMIN UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Moon-Hee Sung, Yong Taik Lim, Young-Woock Noh, Il Han Lee, Hyun Min Kim
-
Patent number: 9095605Abstract: The present invention relates to a pharmaceutical composition for inhibiting or preventing viral infection, which comprises an effective dose of poly-gamma-glutamic acid (?-PGA), and more particularly, to a pharmaceutical composition, a functional food, and a feedstuff additive capable of inhibiting viral infection and preventing viral diseases, which comprise poly-gamma-glutamic acid having an infection-inhibiting effect against viruses, such as an influenza virus, inducing respiratory infection or systemic infection, as an effective ingredient. The composition containing poly-gamma-glutamic acid as an effective ingredient according to the present invention, is effective for use as an animal feedstuff additive or a pharmaceutical agent for preventing influenza virus infection and various viral diseases as well as a pharmaceutical composition and a functional food to promote human health.Type: GrantFiled: September 16, 2011Date of Patent: August 4, 2015Assignees: BIOLEADERS CORPORATION, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGYInventors: Moon-Hee Sung, Chul Joong Kim, Haryoung Poo, Young-Ki Choi, Il Han Lee, Dai-Won Yoo
-
Publication number: 20140170077Abstract: The present invention relates to a nano-composite containing anionic and cationic polymers and a method for preparing thereof, and more particularly to a poly-gamma-glutamic acid (?-PGA)/chitosan/manganese iron oxide nanoparticle composite prepared by encapsulating iron oxide-based nanoparticles in a ?-PGA/chitosan polymer composite using the ionic self-assembly properties of poly-gamma-glutamic acid (?-PGA) and chitosan, which are biocompatible polymer materials, and to a method for preparing thereof. The present invention provides a magnetic resonance imaging nano-contrast agent based on a nanoparticle composite including iron oxide-based nanoparticles encapsulated in a self-assembled composite of anionic poly-gamma-glutamic acid (?PGA) and cationic chitosan.Type: ApplicationFiled: April 7, 2011Publication date: June 19, 2014Applicants: THE INDUSTRY AND ACADEMIC COOPERATION IN CHUNGNAM, BIOLEADERS CORPORATIONInventors: Moon-Hee Sung, Yong Taik Lim, Young-Woock Noh, Il Han Lee, Hyun Min Kim
-
Patent number: 8685721Abstract: A surface expression vector for preparing HPV immunogenic compositions, in which the surface expression vector contains a gene encoding a repE mutant protein having an amino acid sequence of SEQ ID NO: 1, a promoter, a poly-gamma-glutamate synthetase complex gene, and a gene which is linked with the poly-gamma-glutamate synthetase complex gene and encodes a tumor induction-associated antigen protein of human papillomavirus. An expression vector constitutively expressing a high level of the human papillomavirus (HPV) antigen protein is provided. Also, a recombinant lactic acid bacteria, transformed with the expression vector and expressing the HPV antigen protein on the surface thereof, and a composition comprising the recombinant lactic acid bacteria are provided. The recombinant lactic acid bacteria and the composition are very effective as a immunogenic composition for the treatment of cervical cancer, because they can be applied orally or directly to the vagina.Type: GrantFiled: January 8, 2010Date of Patent: April 1, 2014Assignees: Bioleaders Corporation, Kookmin University Industry-Academy Cooperation FoundationInventors: Moon-Hee Sung, Haryoung Poo, Il Han Lee
-
Patent number: 8576798Abstract: A data communication apparatus and method that permits communication between two devices without having to perform a complicated initial connection procedure. A communication unit conducts data transmission/reception with an external data communication apparatus, and a controller controls the communication unit to operate in one of a network mode or a broadcast mode. The network mode conducts network communication via connection through an initial connection procedure with the external data communication apparatus and the broadcast mode receives or transmits data to/from the external data communication apparatus according to a predetermined broadcast method.Type: GrantFiled: August 20, 2010Date of Patent: November 5, 2013Assignee: Samsung Electronics Co., Ltd.Inventors: Cheon-moo Lee, Il-han Lee, Soo-hyun Yoo
-
Patent number: 8236940Abstract: Disclosed herein are an aldolase gene promoter and the use thereof, more particularly, disclosed are a promoter of aldolase gene derived from Lactobacillus casei, having a base sequence of SEQ ID NO: 1, an expression vector containing said promoter, and a recombinant microorganism transformed with said expression vector. The recombinant microorganism transformed with the expression vector containing the disclosed promoter can effectively express a target protein on the surface thereof, and thus will be useful as vaccine vehicles and the like.Type: GrantFiled: March 21, 2008Date of Patent: August 7, 2012Assignees: Bioleaders Corporation, Korea Research Institute of Bioscience and BiotechnologyInventors: Moon Hee Sung, Chul Joong Kim, Seung-Pyo Hong, Haryoung Poo, Il Han Lee, Ji Yeon Kim, Kwang Kim
-
Publication number: 20120010130Abstract: The present invention relates to a pharmaceutical composition for inhibiting or preventing viral infection, which comprises an effective dose of poly-gamma-glutamic acid (?-PGA), and more particularly, to a pharmaceutical composition, a functional food, and a feedstuff additive capable of inhibiting viral infection and preventing viral diseases, which comprise poly-gamma-glutamic acid having an infection-inhibiting effect against viruses, such as an influenza virus, inducing respiratory infection or systemic infection, as an effective ingredient. The composition containing poly-gamma-glutamic acid as an effective ingredient according to the present invention, is effective for use as an animal feedstuff additive or a pharmaceutical agent for preventing influenza virus infection and various viral diseases as well as a pharmaceutical composition and a functional food to promote human health.Type: ApplicationFiled: September 16, 2011Publication date: January 12, 2012Applicants: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, BIOLEADERS CORPORATIONInventors: Moon-Hee SUNG, Chul Joong KIM, Haryoung POO, Young-Ki CHOI, Il Han LEE, Dai-Won YOO
-
Publication number: 20110318384Abstract: A surface expression vector for preparing HPV vaccines, in which the surface expression vector contains a gene encoding a repE mutant protein having an amino acid sequence of SEQ ID NO: 1, a promoter, a poly-gamma-glutamate synthetase complex gene, and a gene which is linked with the poly-gamma-glutamate synthetase complex gene and encodes a tumor induction-associated antigen protein of human papillomavirus. An expression vector constitutively expressing a high level of the human papillomavirus (HPV) antigen protein is provided. Also, a recombinant lactic acid bacteria, transformed with the expression vector and expressing the HPV antigen protein on the surface thereof, and a composition comprising the recombinant lactic acid bacteria are provided. The recombinant lactic acid bacteria and the composition are very effective as a vaccine for the treatment of cervical cancer, because they can be applied orally or directly to the vagina.Type: ApplicationFiled: January 8, 2010Publication date: December 29, 2011Inventors: Moon-Hee Sung, Haryoung Poo, Il Han Lee
-
Publication number: 20110096850Abstract: A data communication apparatus and method that permits communication between two devices without having to perform a complicated initial connection procedure. A communication unit conducts data transmission/reception with an external data communication apparatus, and a controller controls the communication unit to operate in one of a network mode or a broadcast mode. The network mode conducts network communication via connection through an initial connection procedure with the external data communication apparatus and the broadcast mode receives or transmits data to/from the external data communication apparatus according to a predetermined broadcast method.Type: ApplicationFiled: August 20, 2010Publication date: April 28, 2011Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: Cheon-moo LEE, Il-han LEE, Soo-hyun YOO